Regulations.gov document
Attachment 1 - Orange Book Listing (April 7, 2025) DELATESTRYL® (Testosterone Enanthate…
Supporting & Related Material · FDA-2025-P-1085 · posted Apr 15, 2025
Key facts
| Document ID | FDA-2025-P-1085-0003 |
|---|---|
| Title | Attachment 1 - Orange Book Listing (April 7, 2025) DELATESTRYL® (Testosterone Enanthate Injection, USP) |
| Document type | Supporting & Related Material |
| Subtype | Background Material |
| Agency | FDA |
| Docket | FDA-2025-P-1085 |
| Posted | Apr 15, 2025 |
At a glance
- None Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: